Testing COVID-19 therapies to prevent progression of mild disease
Lancet Infect Dis
2020 May 6;S1473-3099(20)30372-8.
Online ahead of print.
Matthew K Waldor
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Electronic address: firstname.lastname@example.org.
Department of Microbiology and Immunology and Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
Department of Medicine and Department of Microbiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
No abstract available